Live Breaking News & Updates on யுனிவர்சிடேட் டி ஸ்ம் பாலொ

Stay updated with breaking news from யுனிவர்சிடேட் டி ஸ்ம் பாலொ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NIMH » Latin America Treatment & Innovation Network in Mental Health — LATIN-MH


Overview
Latin-MH is a regional hub for mental health research and training that aims to decrease the treatment gap in Latin America and the Caribbean for people with comorbid mental and chronic physical diseases. Depression is the second leading contributor to the health burden in this region; yet, only a small proportion of individuals with depression receive treatment. Moreover, many individuals with depression also have chronic physical illnesses, leading to poorer outcomes for both conditions. To address this issue, Latin-MH is evaluating the effectiveness of a low-intensity psycho-educational intervention delivered via smartphones for individuals with depressive symptoms and diabetes or hypertension. Latin-MH is also building mental health research capacity in the region through a research training program delivered by a network involving Universidade de Sao Paulo, Brazil; Universidad Peruana Cayetano Heredia in Lima, Peru; Northwestern University in Chicago, United Stat ....

Northwestern University , United States , United Kingdom , Universidad Peruana Cayetano Heredia , Paulo Menezes , Ricardo Arraya , Innovation Network In Mental Health , London School Of Hygiene , Latin America Treatment , Innovation Network , Mental Health , America Treatment , Principal Investigator , Latin America , Universidade De Sao Paulo , London School , Tropical Medicine , வடமேற்கு பல்கலைக்கழகம் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , யுனிவர்சிடாட் பெருவானா கேயேதானோ பரம்பரை , பாலொ மெனிசஸ் , லண்டன் பள்ளி ஆஃப் சுகாதாரம் , கண்டுபிடிப்பு வலைப்பின்னல் , மன ஆரோக்கியம் , அமெரிக்கா சிகிச்சை ,

Vitamin D Flops in Moderate-Severe COVID


email article
Among patients with moderate to severe COVID-19, there was no difference in length of hospital stay in those given a single 200,000-IU dose of vitamin D
3 versus those given placebo in a randomized trial in Brazil.
Median length of hospital stay was about 7 days for both groups, with no significant differences in secondary outcomes including in-hospital mortality, admission to ICU, or need for mechanical ventilation, reported Rosa Pereira, MD, PhD, of Universidade de Sao Paulo, and colleagues in an online edition of
An accompanying editorial by David Leaf, MD, of Brigham and Women s Hospital in Boston, and Adit Ginde, MD, MPH, of University of Colorado School of Medicine in Aurora, noted that prior research showed that lower levels of vitamin D were independently associated with worse outcomes in patients with acute illness, but also that vitamin D supplementation as a treatment had no impact on clinical outcomes. ....

United States , Sao Paulo , Molly Walker , David Leaf , Rosa Pereira , University Of Colorado School Medicine , Universidade De Sao Paulo , Adit Ginde , Colorado School , Common Cold , Influenza Like Illness , Disorder Of Respiratory System , ஒன்றுபட்டது மாநிலங்களில் , ஸ்ம் பாலொ , மாலீ வாக்கர் , டேவிட் இலை , ரோசா பெரேரா , பல்கலைக்கழகம் ஆஃப் கொலராடோ பள்ளி மருந்து , யுனிவர்சிடேட் டி ஸ்ம் பாலொ , கொலராடோ பள்ளி , பொதுவானது குளிர் , கோளாறு ஆஃப் சுவாச அமைப்பு ,